NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs051180216

Registered date:27/03/2019

Sentinel node biopsy in uterine cancer

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedUterine cancer
Date of first enrollment17/08/2017
Target sample size400
Countries of recruitment
Study typeInterventional
Intervention(s)Sentinel navigation surgery

Outcome(s)

Primary OutcomeProgression free survival
Secondary OutcomeThe rate of postoperative lymph edema and lymph node recurrence

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 85age old
GenderFemale
Include criteriaCervical cancer of stage I with tumor diameter of less than 2 cm, endometrial cancer of stage IA with endometrioid carcinoma of grade 1 or 2
Exclude criteriaSuspicious of lymph node metastasis on preoperative image findings Neoadjuvant chemotherapy and radiotherapy

Related Information

Contact

Public contact
Name Tomohito Tanaka
Address 2-7, Daigakumachi, Takatsuki, Osaka 569-8686, Japan Osaka Japan 569-8686
Telephone +81-72-683-1221
E-mail tomohito.tanaka@ompu.ac.jp
Affiliation Osaka Medical and Pharmaceutical University Hospital
Scientific contact
Name Masahide Ohmichi
Address 2-7, Daigakumachi, Takatsuki, Osaka 569-8686, Japan Osaka Japan 569-8686
Telephone +81-72-683-1221
E-mail m-ohmichi@ompu.ac.jp
Affiliation Osaka Medical and Pharmaceutical University Hospital